Fig. 2From: Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 monthsComputed tomography (CT) scan performed during trametinib treatment: images showing right axillary lymphadenopathy, liver metastasis, right hilar lymphadenopathy, T7 vertebral body metastasis and subcutaneous node are shownBack to article page